6JMD

Crystal structure of human DHODH in complex with inhibitor 1223

Summary for 6JMD

• Entry DOI: 10.2210/pdb6jmd/pdb
• Descriptor: Dihydroorotate dehydrogenase (quinone), mitochondrial, FLAVIN MONONUCLEOTIDE, OROTIC ACID, ... (8 entities in total)
• Functional Keywords: dhodh, inhibitor, complex, oxidoreductase, oxidoreductase-oxidoreductase inhibitor complex, oxidoreductase/oxidoreductase inhibitor
• Biological source: Homo sapiens (Human)
• Total number of polymer chains: 1
• Total formula weight: 41294.76

Authors

Yu, Y.,Chen, Q. (deposition date: 2019-03-08, release date: 2020-03-18, Last modification date: 2024-03-27)

Primary citation

Zuo, Z.,Liu, X.,Qian, X.,Zeng, T.,Sang, N.,Liu, H.,Zhou, Y.,Tao, L.,Zhou, X.,Su, N.,Yu, Y.,Chen, Q.,Luo, Y.,Zhao, Y.
Bifunctional Naphtho[2,3- d ][1,2,3]triazole-4,9-dione Compounds Exhibit Antitumor Effects In Vitro and In Vivo by Inhibiting Dihydroorotate Dehydrogenase and Inducing Reactive Oxygen Species Production.
J.Med.Chem., 63:7633-7652, 2020

PubMed Abstract: Human dihydroorotate dehydrogenase (DHODH) is an attractive target for cancer therapy. Based on its crystal structure, we designed and synthesized a focused compound library containing the structural moiety of 1,4-benzoquinone, which possesses reactive oxygen species (ROS) induction capacity. Compound with a naphtho[2,3-][1,2,3]triazole-4,9-dione scaffold exhibited inhibitory activity against DHODH. Further optimization led to compounds and , which inhibited DHODH activity with IC values of 9 and 4.5 nM, respectively. Protein-ligand cocrystal structures clearly depicted hydrogen bond and hydrophobic interactions of and with DHODH. Compounds and significantly inhibited leukemia cell and solid tumor cell proliferation and induced ROS production, mitochondrial dysfunction, apoptosis, and cell cycle arrest. Nanocrystallization of compound displayed significant in vivo antitumor effects in the Raji xenograft model. Overall, this study provides a novel bifunctional compound with DHODH inhibition and ROS induction efficacy, which represents a promising anticancer lead worthy of further exploration.

PubMed: 32496056
DOI: 10.1021/acs.jmedchem.0c00512

Experimental method

X-RAY DIFFRACTION (1.781 Å)